Stocks and Investing Stocks and Investing
Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022

Justin Zelin Maintained (CASI) at Strong Buy with Increased Target to $21 on, Jun 3rd, 2022


Published on 2024-10-27 21:24:57 - WOPRAI, Justin Zelin
  Print publication without navigation


Justin Zelin of BTIG, Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $4 to $21 on, Jun 3rd, 2022.

Justin has made no other calls on CASI in the last 4 months.



There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Justin's Rating of Hold.



This is the rating of the analyst that currently disagrees with Justin


  • Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022
Contributing Sources